Downingtown, PA, United States of America

Mary E Roberts


Average Co-Inventor Count = 4.4

ph-index = 6

Forward Citations = 380(Granted Patents)


Company Filing History:


Years Active: 1994-2001

Loading Chart...
12 patents (USPTO):

Title: The Innovative Contributions of Mary E. Roberts

Introduction

Mary E. Roberts is a distinguished inventor based in Downingtown, Pennsylvania, known for her significant contributions to the field of pharmaceutical formulations. With a total of 12 patents to her name, she has made remarkable advancements in the treatment of diseases, particularly those related to human immunodeficiency virus (HIV).

Latest Patents

Among her latest patents, Roberts has developed methods of treating mammals using nanocrystalline formulations of HIV protease inhibitors. These formulations include a cellulosic surface stabilizer, which enhances the rate of dissolution in vitro and absorption in vivo. Additionally, her inventions demonstrate a decreased fed/fasted ratio variability and reduced variability in absorption. The patents specifically address nanoparticulate formulations of HIV type 1 (HIV-1) and type 2 (HIV-2) protease inhibitors, showcasing her innovative approach to improving therapeutic efficacy.

Career Highlights

Throughout her career, Mary E. Roberts has worked with notable companies such as Sterling Winthrop Inc. and Elan Pharma International Limited. Her experience in these organizations has contributed to her expertise in pharmaceutical development and innovation.

Collaborations

Roberts has collaborated with esteemed colleagues, including Stephen B. Ruddy and Gregory L. McIntire, further enhancing her research and development efforts in the field of HIV treatment.

Conclusion

Mary E. Roberts stands out as a pioneering inventor whose work has significantly impacted the pharmaceutical industry. Her innovative formulations and dedication to improving treatment options for HIV demonstrate her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…